IMF seers should admit ignorance - or get a grip

Wrong variables

Reuters

There's no preparation for debt-ceiling collapse

Fingers crossed

Business Standard

Political decay threatens developed economies

No laughing matter

US does what it can to de-reserve the dollar

Feeding future sharks

Bernanke is trapped by a discredited assumption

Intellectual stagnation

Financial system can still knock economies off course

The known unknown

Next Fed boss could learn from Carney's bad start

Don't think hard

Better than a kick in the face

Markets, central bankers face strange new world

Spot the problem

China's next reform: more central planning

Think big, act small

From survive to thrive

Detroit bankruptcy has lesson for the Euro zone

Political firewalls

GSK finds toxic side effects in Chinese marketGlaxoSmithKline has a problem in China. The Chinese authorities have a problem that goes well beyond the UK pharmaceutical maker.The GSK problem has a familiar ring. Along with US rivals Pfizer and Johnson & Johnson, GSK settled American bribery cases. It is all too easy for these makers of high-margin products to share some of the revenue with the doctors who write prescriptions. The manufacturer, doctor and non-paying patients are all happy. Those who actually pay for the junkets and favours are often left to fume. In China, that is usually the patients.The Chinese authorities have gone beyond fuming. The Ministry of Public Security accused GSK of transferring up to 3 billion yuan ($489 million) of kickbacks to over 700 travel agencies and consultancies. The goal was to increase market share in a pharmaceutical market worth $181 billion last year. The company says it has "zero tolerance" for such activities, and has cut off business w

China, heal thyself

The ship has sailed

Global recovery: this time it's different

Enjoy it while it lasts

Policymakers who see no bubble might still get wet

No such thing as safe QE

Get used to it

Turkish example weighs on emerging markets

Red flag

Higher yields, the next great financial threat

Not yet, if you please

The Great Stagnation spawns Great Confusion

Edward Hadas